Cerevel Therapeutics Holdings, Inc. (CERE) NASDAQ

44.96

+0.33(+0.74%)

Updated at July 31, 2024 04:00PM

Currency In USD

Valuation

Market Cap6.87B
Enterprise Value6.36B
P/E Ratio-16.83
PEG Ratio-0.17
Price/Sales Ratio0
Price/Book Ratio10.81
Enterprise/Revenue0
Enterprise/EBITDA-17.39

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterMarch 31, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.35
Return On Equity-0.72

Income Statement

Revenue0
Revenue/Share0
Gross Profit-5.63M
EBITDA-416.15M
Net Income-432.84M
Diluted EPS-2.67

Balance Sheet

Total Cash846.29M
Total Cash/Share9.66
Total Debt368.3M
Total Debt/Equity0.71
Current Ratio10.92
Book Value Per Share4.16

Price History

52-Week Change87.88
52-Week High44.99
52-Week Low19.59
Moving Average 50 Days41.6
Moving Average 200 Days38.67

Statistics

Average Volume2.06M
Shares Outstanding182.2M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A